NQR enzyme is vital for energy production in pathogenic bacteria like the one that causes cholera, making it a highly ...
Leveraging cross-reactive monoclonals and next-generation vaccines to address Crimean-Congo hemorrhagic fever virus diversity ...
CD73 inhibitors present significant opportunities in cancer immunotherapy by reversing immunosuppression in tumors and enhancing immune response. Novel antibodies, RNA, and small molecules are in ...
Genetically altered bacteria can synthesise gadusol, a naturally occurring compound found in zebrafish eggs that could be ...
Though largely operating in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is set ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...
ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing in ...
The Department of Defense is signing new deals with defense companies to boost production of critical weapons. Key missiles and interceptors have seen extensive use in recent conflicts. Officials and ...
Growth often gets discussed in numbers, associating with valuation, revenue, expansion and the like. However, these figures can rarely explain how a company endures when conditions turn hostile. In ...
Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results